Clinical Trials Browser

Phase 1 × Uterine Cervical Neoplasms × veliparib × Clear all

NCT01281852 2019-07-18

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Phase 1 Completed

Uterine Cervical Neoplasms